ReviewClinical, cosmetic and investigational dentistry2026
Comparative Analysis of Different Origin-Derived Exosomes for Future Regenerative Endodontic Therapies: A Systematic Review.
Review in Clinical, cosmetic and investigational dentistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Exosomes are gaining considerable attention as a cell-free approach for regenerative endodontic procedures, because they naturally regulate cell signaling and actively drive tissue healing. However, the regenerative potential of exosomes may vary by cellular origin, highlighting the need to evaluate source-dependent therapeutic applications. Objective: This systematic review aimed to compare the regenerative potential of exosomes derived from different cellular sources and assess their biological effects, molecular mechanisms, and translational relevance for regenerative endodontic therapies. Methods: A systematic review following PRISMA flow chart 2020 guidelines and a percentage summary of risk-of-bias assessment using the Modified SYRCLE Risk of Bias tool identified 216 eligible studies from PubMed, Web of Science, and Scopus, with 30 studies included in the final detailed synthesis. Results: Evidence consistently demonstrated that exosomes promote cell proliferation, migration, odontogenic differentiation, angiogenesis, and immunomodulation through signaling pathways including AKT, ERK, PI3K/AKT, Wnt/β-catenin, and TGF-β/SMAD. Exosomes derived from dental stem cells exhibited superior tissue-specific regenerative and odontogenic potential, making them particularly suitable for dental pulp regeneration. In contrast, exosomes from non-dental sources offered advantages in accessibility, scalability, and enhancement of early proliferative and angiogenic responses. Furthermore, engineered exosomes and advanced delivery platforms, including hydrogels and biomaterial-based scaffolds, improved therapeutic efficacy by enhancing cargo stability, retention, and targeted tissue regeneration. Conclusion: Exosome-based therapies represent a promising strategy for regenerative endodontics, with therapeutic outcomes strongly influenced by exosome source. Endogenous sources, such as DPSC-derived exosomes, appear most suitable for pulp-dentin complex regeneration but are less practical than exogenous sources, such as PRP, WJMSC, and ADSVF exosomes, for scalable clinical applications. To reach the clinic, upcoming studies need to standardize exosome isolation and profiling, pinpoint specific clinical uses for each source, and incorporate modern delivery biomaterials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.